Omacetaxine Dosage
Applies to the following strengths: 3.5 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Myelogenous Leukemia
Induction dose: 1.25 mg/m2 subcutaneously twice daily for 14 consecutive days of a 28 day cycle.
Maintenance dose: 1.25 mg/m2 subcutaneously twice daily for 7 consecutive days of a 28 day cycle.
Use: Chronic or accelerated phase CML with resistance and/or intolerance to two or more tyrosine kinase inhibitors.
Comments: There are no trials verifying an improvement in disease-related symptoms or increased survival with omacetaxine.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
- For hematologic toxicities, omacetaxine treatment cycles may be delayed.
- If a patient experiences Grade 4 neutropenia (absolute neutrophil count (ANC) less than 0.5 x 10(9)/L) or Grade 3 thrombocytopenia (platelet counts less than 50 x 10(9)/L) during a cycle, delay starting the next cycle until ANC is greater than or equal to 1.0 x 10(9)/L and platelet count is greater than or equal to 50 x 10(9)/L. Also, for the next cycle, reduce the number of dosing days by 2 days (e.g. to 12 or 5 days).
- For other clinically significant nonhematologic toxicity manage symptomatically. Interrupt and/or delay omacetaxine until toxicity is resolved.
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For subcutaneous injection
- May be administered in the home setting. The manufacturer's product information should be consulted for further information.
Reconstitution/preparation techniques:
- Reconstitute with 1 mL of 0.9% sodium chloride injection, USP.
- The manufacturer's product information should be consulted for detailed reconstitution information.
Storage requirements (reconstituted):
- Room Temperature: Use within 12 hours of reconstitution.
- Refrigerated: Use within 6 days of reconstitution.
- Protect reconstituted solution from light.
More about omacetaxine
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: miscellaneous antineoplastics
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.